HomeCompareSWRAY vs JNJ

SWRAY vs JNJ: Dividend Comparison 2026

SWRAY yields 3.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SWRAY wins by $170.5K in total portfolio value
10 years
SWRAY
SWRAY
● Live price
3.76%
Share price
$11.06
Annual div
$0.42
5Y div CAGR
44.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$190.5K
Annual income
$80,861.04
Full SWRAY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SWRAY vs JNJ

📍 SWRAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSWRAYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SWRAY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SWRAY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SWRAY
Annual income on $10K today (after 15% tax)
$319.47/yr
After 10yr DRIP, annual income (after tax)
$68,731.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SWRAY beats the other by $68,028.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SWRAY + JNJ for your $10,000?

SWRAY: 50%JNJ: 50%
100% JNJ50/50100% SWRAY
Portfolio after 10yr
$105.3K
Annual income
$40,844.41/yr
Blended yield
38.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SWRAY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.9
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SWRAY buys
0
JNJ buys
0
No recent congressional trades found for SWRAY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSWRAYJNJ
Forward yield3.76%3.36%
Annual dividend / share$0.42$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR44.1%5.8%
Portfolio after 10y$190.5K$20.0K
Annual income after 10y$80,861.04$827.78
Total dividends collected$157.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SWRAY vs JNJ ($10,000, DRIP)

YearSWRAY PortfolioSWRAY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,242$541.60$10,676$355.77+$566.00SWRAY
2$12,848$819.95$11,407$389.39+$1.4KSWRAY
3$15,010$1,262.09$12,198$426.53+$2.8KSWRAY
4$18,046$1,985.63$13,056$467.62+$5.0KSWRAY
5$22,525$3,215.04$13,987$513.12+$8.5KSWRAY
6$29,506$5,404.25$14,998$563.56+$14.5KSWRAY
7$41,105$9,533.73$16,098$619.52+$25.0KSWRAY
8$61,869$17,886.72$17,295$681.69+$44.6KSWRAY
9$102,456$36,256.92$18,599$750.82+$83.9KSWRAY
10$190,489$80,861.04$20,022$827.78+$170.5KSWRAY

SWRAY vs JNJ: Complete Analysis 2026

SWRAYStock

Swire Pacific Limited engages in property, aviation, beverages, marine, and trading and industrial businesses in Hong Kong, Mainland China, rest of Asia, the United States, and internationally. The company's Property division develops, owns, and operates mixed-use properties. This division's property investment portfolio comprises office and retail premises, serviced apartments, other luxury residential accommodations, and commercial mixed-use developments; and trading portfolio consists of residential properties. It also owns and manages two hotels in Hong Kong and four hotels in Mainland China, as well as owns interests in the Mandarin Oriental hotel in the United States. The company's Aviation division provides flight catering and ramp, passenger and cargo services, and aircraft maintenance and modification services. As of December 31, 2021, it had a fleet of 234 aircraft. Its Beverages division owns rights to manufacture, market, and distribute refreshing soft drinks to consumers. The company's Trading & Industrial division retails and distributes footwear, apparel, and accessories through its 164 retail outlets; sells passenger cars, commercial vehicles, motorcycles, and scooters; operates a chain of 538 bakery stores; packages and sells sugar products under the Taikoo Sugar brand; and offers waste management services. The company was founded in 1816 and is based in Central, Hong Kong.

Full SWRAY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SWRAY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SWRAY vs SCHDSWRAY vs JEPISWRAY vs OSWRAY vs KOSWRAY vs MAINSWRAY vs ABBVSWRAY vs MRKSWRAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.